Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular smooth muscle intracellular calcium-handling machinery is a coordinated system of ion channels, transporters, and signaling proteins that regulate cytosolic calcium levels to control vascular tone and diameter (Berridge, 2008; Journal of Physiology). Key components include the sarcoplasmic reticulum (SR), which acts as an internal calcium store, and various proteins such as the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA), Ryanodine Receptors (RyR), and Inositol Trisphosphate Receptors (IP3R) (Kuo & Ehrlich, 2015; Cold Spring Harbor Perspectives in Biology). In vascular smooth muscle cells, an increase in intracellular calcium triggers contraction through the activation of myosin light chain kinase, while its removal or sequestration leads to relaxation (StatPearls, 2023). Dysregulation of this machinery is a hallmark of cardiovascular diseases, including hypertension and pulmonary arterial hypertension, where excessive calcium signaling leads to chronic vasoconstriction and structural remodeling of the vessel wall (NIH/NCBI, 2022). Therapeutic strategies often involve modulating this machinery using calcium channel blockers to prevent influx or vasodilators that promote calcium reuptake and efflux (PubChem, 2024). Consequently, this system is a central focus for pharmacological intervention in managing blood pressure and improving vascular hemodynamics. Notable drugs targeting this machinery include dihydropyridines like amlodipine and non-dihydropyridines like verapamil, which primarily inhibit L-type calcium channels (StatPearls, 2023). Emerging research also explores the role of store-operated calcium entry (SOCE) through Orai and STIM proteins as potential therapeutic targets for vascular proliferative diseases (PubMed, 2021).
Modulation of intracellular calcium levels through the inhibition of plasma membrane calcium channels, activation of sequestration pumps (SERCA), or inhibition of intracellular release channels (RyR/IP3R).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular smooth muscle intracellular calcium-handling machinery (VSM Ca2+ machinery).